Poveda A, Lheureux S, Colombo N, Cibula D, et al. Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial. Gynecol Oncol 2025;197:74-82.
PMID: 40300425